البحث عن طبيب

Afsaneh Alavi, M.D.

  1. Dermatologist
طلب موعد

المنشورات

  1. Shakshouk H, Hines A, Kody S, Fett N, Alavi A, Ortega-Loayza AG. Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis. J Am Acad Dermatol. 2024 Dec; 91 (6):1035-1048 Epub 2024 Mar 01
    View PubMed
  2. Hines A, Kody S, Shakshouk H, Fett N, Alavi A, Ortega-Loayza AG. Inflammatory and vaso-occlusive ulcers: Part II - Management. J Am Acad Dermatol. 2024 Dec; 91 (6):1051-1066 Epub 2024 Mar 01
    View PubMed
  3. Akpala CO, Erfani YJ, Young J, Saeidi V, Todd A, Chelf C, Philips EJ, Alavi A. Stevens-Johnson syndrome and toxic epidermal necrolysis-like eruptions in patients treated with immune checkpoint inhibitors: a systematic review. Int J Dermatol. 2024 Dec; 63 (12):e397-e404 Epub 2024 Sept 16
    View PubMed
  4. Kimball AB, Bechara FG, Badat A, Giamarellos-Bourboulis EJ, Gottlieb AB, Jemec GBE, Reguiai Z, Villani AP, Alarcon I, Bansal A, Gasperoni F, Martin R, Paguet B, Uhlmann L, Zouater H, Ravichandran S, Alavi A. Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial. Br J Dermatol. 2024 Nov 29 [Epub ahead of print]
    View PubMed
  5. King AL, Johnson EF, Alavi A, Agrawal S, Sokumbi O, Perelygina L, Yorke L, Beard S, Wieland CN. The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency. J Cutan Pathol. 2024 Nov 26 [Epub ahead of print]
    View PubMed
  6. Ziebart RL, Haberecht H, Davis MD, Wetter DA, Sartori-Valinotti JC, Cantwell HM, McEvoy MT, Mohandesi NA, Iverson OC, Todd A, Phillips E, Alavi A. Vancomycin-associated drug induced hypersensitivity syndrome: A retrospective cohort study. J Am Acad Dermatol. 2024 Nov; 91 (5):1008-1011 Epub 2024 July 29
    View PubMed
  7. Zouboulis CC, Kyrgidis A, Alavi A, Jemec GBE, Martorell A, Marzano AV, van der Zee HH, Wozniak MB, Martinez AL, Kasparek T, Bachhuber T, Ortmann CE, Lobach I, Thomas N, Ravichandran S, Tzellos T. Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials. J Eur Acad Dermatol Venereol. 2024 Oct 19 [Epub ahead of print]
    View PubMed
  8. Yamanaka-Takaichi M, Nadalian S, Loftus EV, Ehman EC Jr, Todd A, Grimaldo AB, Yalon M, Matchett CL, Patel NB, Isaq NA, Raffals LE, Wetter DA, Murphree DH Jr, Cima RR, Dozois EJ, Goldfarb N, Tizhoosh HR, Alavi A. Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa. Int J Dermatol. 2024 Sep 22 Epub 2024 Sept 22
    View PubMed
  9. Alavi A, Prens EP, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao H, Ranganathan U, Ivanoff NB, Hernandez Daly AC, Zouboulis CC. Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial. Br J Dermatol. 2024 Sep 18; 191 (4):508-518
    View PubMed
  10. McKenzie N, Schaefer L, Killian J, Youssef M, Alavi A, Davis M. Allergic Contact Dermatitis in Patients With Hidradenitis Suppurativa: A Retrospective Analysis. Dermatitis 2024 Sep-Oct; 35 (5):525-527 Epub 2024 Jan 03
    View PubMed
  11. Shojaei D, Zabihi H, Maida V, Kirchhof MG, Alavi A. Evaluation of Cannabis-Related Product Use Among Patients With Hidradenitis Suppurativa: A Narrative Review. J Cutan Med Surg. 2024 Sep-Oct; 28 (5):481-485 Epub 2024 July 31
    View PubMed
  12. Imhof RL, Dai C, Alavi A, Sokumbi O. Management and outcomes of hidradenitis suppurativa in solid organ transplant recipients. Br J Dermatol. 2024 Aug 18 [Epub ahead of print]
    View PubMed
  13. Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024 Aug 1; 37 (8):406-411
    View PubMed
  14. Wanberg LJ, Gorman BG, Theis-Mahon N, Goldfarb N, Alavi A. Management of pyoderma gangrenosum during pregnancy and breastfeeding: a systematic review. Int J Dermatol. 2024 Jul 31 Epub 2024 July 31
    View PubMed
  15. McDonald A, Karnik R, Campbell V, Davis J, Chavoshi S, Slavin A, Sharma K, Gollob J, Alavi A. IRAK4 Is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers. J Invest Dermatol. 2024 Jul 29 Epub 2024 July 29
    View PubMed
  16. Shakhashiro M, Sadeghian S, Newcomer J, Marzano AV, Maronese CA, Davis JM 3rd, Alavi A. Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations. Int J Dermatol. 2024 Jul 4 Epub 2024 July 04
    View PubMed
  17. Becker SL, Kody S, Fett NM, Hines A, Alavi A, Ortega-Loayza AG. Approach to the Atypical Wound. Am J Clin Dermatol. 2024 Jul; 25 (4):559-584 Epub 2024 May 14
    View PubMed
  18. Yamanaka-Takaichi M, Watanabe M, Comfere NI, Sokumbi O, Akpala CO, Todd A, Branch EL, Mangold AR, Hiroyasu S, Tsuruta D, Alavi A. Differentiating generalized pustular psoriasis from acute generalized exanthematous pustulosis. J Am Acad Dermatol 2024 Jun; 90 (6):1289-1291 Epub 2024 Mar 14
    View PubMed
  19. Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group. J Invest Dermatol. 2024 Jun; 144 (6):1295-1300.e6 Epub 2023 Dec 16
    View PubMed
  20. Needham M, Pichardo R, Alavi A, Chang AY, Daveluy S, DeNiro KL, Dewan A, Eshaq M, Fox L, Hsiao JL, Kaffenberger BH, Kirby JS, Kroshinsky D, Ortega-Loayza AG, Manusco JB, Micheletti RG, Mostaghimi A, Nelson CA, Pasieka HB, Porter ML, Resnik BI, Sayed CJ, Shi VY, Shields BE, Strowd LC. Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study. Cutis. 2024 Jun; 113 (6):251-254
    View PubMed
  21. Saeidi V, Garimella V, Shaji K, Wetter DA, Davis MDP, Todd A, Dutz J, Alavi A. Monoclonal gammopathy in the setting of Pyoderma gangrenosum. Arch Dermatol Res. 2024 May 25; 316 (6):268
    View PubMed
  22. Garimella V, Anand N, Campbell EH, Baum CL, Alavi A. Lower Extremity Angiosarcoma: A Life-Threatening Complication of Lymphedema. Adv Skin Wound Care. 2024 May 1; 37 (5):268-270
    View PubMed
  23. Brydges HT, Onuh OC, Friedman R, Barrett J, Betensky RA, Lu CP, Caplan AS, Alavi A, Chiu ES. Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study. Am J Clin Dermatol. 2024 May; 25 (3):473-484 Epub 2024 Feb 09
    View PubMed
  24. Greenlund L, Herzog C, Wendland Z, Rypka K, Frew JW, Kirby JS, Alavi A, Khalid B, Lowes MA, Garg A, Marzano AV, Zouboulis CC, Tzellos T, Jaleel T, Goldfarb N. Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients. J Eur Acad Dermatol Venereol. 2024 Apr 10 [Epub ahead of print]
    View PubMed
  25. Yamanaka-Takaichi M, Alavi A. Palisaded Neutrophilic Granulomatous Dermatitis, Bowel-Associated Dermatosis-Arthritis Syndrome, and Rheumatoid Neutrophilic Dermatitis. Dermatol Clin. 2024 Apr; 42 (2):297-305 Epub 2023 Sept 09
    View PubMed
  26. Imhof RL, Todd A, Davidge-Pitts CJ, Alavi A. Hidradenitis suppurativa in transgender and gender diverse patients: A retrospective review with examination of the role of hormone therapy. J Am Acad Dermatol. 2024 Apr; 90 (4):845-847 Epub 2023 Dec 10
    View PubMed
  27. Maniam GB, Coakley A, Huong Nguyen G, Alavi A, Davis MDP. Neutrophilic Panniculitides. Dermatol Clin. 2024 Apr; 42 (2):285-295 Epub 2023 Sept 14
    View PubMed
  28. Yamanaka-Takaichi M, Demer AM, Baum CL, Theoharides TC, Alavi A. The role of mast cells and related molecules in itch of hidradenitis suppurativa. Exp Dermatol. 2024 Mar; 33 (3):e15061
    View PubMed
  29. Kirby JS, Okun MM, Alavi A, Bechara FG, Zouboulis CC, Brown K, Santos LL, Wang A, Bibeau KB, Kimball AB, Porter ML. Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study. J Am Acad Dermatol. 2024 Mar; 90 (3):521-529 Epub 2023 Oct 21
    View PubMed
  30. Smart H, Sibbald RG, Goodman L, Ayello EA, Jaimangal R, Gregory JH, Akita S, Alavi A, Armstrong DG, Arputhanathan H, Bruwer F, Caul J, Chan B, Cronje F, Dofitas B, Hamed J, Harley C, Heil J, Hill M, Jahnke D, Kalina D, Kodange C, Kotru B, Kozody LL, Landis S, Leblanc K, MacDonald M, Mark T, Martin C, Mayer D, Murphy C, Nair H, Orellana C, Ostrow B, Queen D, Rainville P, Rajhathy E, Schultz G, Somayaji R, Stacey MC, Tariq G, Weir G, Whiteside C, Yifter H, Zacharias R. Wound bed preparation 2024: Delphi consensus on foot ulcer management in resource-limited settings. Advances in Skin and Wound Care. 2024; 37 (4):180-96
  31. Maniam GB, Isaq N, Wetter DA, Cantwell HM, McEvoy MT, el-Azhary RA, Alavi A, Camilleri MJ, Davis MDP, Sartori-Valinotti JC. Value of dermatology hospital conference as a continuing medical education-accredited activity: A retrospective review. JEADV Clinical Practice. 2024; 3 (2):647-52
  32. Williamson KA, Samec MJ, Patel JA, Orandi AB, Wang B, Crowson CS, Loftus EV Jr, Alavi A, Moyer AM, Davis JM 3rd. Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series. Front Immunol. 2024; 15:1304792 Epub 2024 Oct 04
    View PubMed
  33. Bouazzi D, Andersen RK, Vinding GR, Medianfar CE, Nielsen SM, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J, Christensen R, Jemec GBE. The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis. Dermatology. 2024; 240 (3):369-375 Epub 2024 Feb 14
    View PubMed
  34. Wanberg LJ, Fletcher KM, Goldfarb N, Alavi A. Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol JEADV Clinical Practice. 12/11/2023.
  35. Ackerman L, Acloque G, Bacchelli S, Schwartz H, Feinstein BJ, La Stella P, Alavi A, Gollerkeri A, Davis J, Campbell V, McDonald A, Agarwal S, Karnik R, Shi K, Mishkin A, Culbertson J, Klaus C, Enerson B, Massa V, Kuhn E, Sharma K, Keaney E, Barnes R, Chen D, Zheng X, Rong H, Sabesan V, Ho C, Mainolfi N, Slavin A, Gollob JA. IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. Nat Med. 2023 Dec; 29 (12):3127-3136 Epub 2023 Nov 13
    View PubMed
  36. Chopra D, Anand N, Brito S, Coutts PM, George R, Kimball AB, Kirsner RS, Alavi A, Lev-Tov H. Wound care for patients with hidradenitis suppurativa: Recommendations of an international panel of experts. J Am Acad Dermatol. 2023 Dec; 89 (6):1289-1292 Epub 2023 Aug 20
    View PubMed
  37. Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG, UPGRADE . A core domain set for pyoderma gangrenosum trial outcomes - an international e-Delphi and consensus study from the UPGRADE initiative. Br J Dermatol. 2023 Nov 11 [Epub ahead of print]
    View PubMed
  38. Anand NC, Campbell EH, Baum CL, Gibson LE, Todd A, Bradt JL, Alavi A. Association of Lower Extremity Lymphedema and Nonmelanoma Skin Cancers. Mayo Clin Proc. 2023 Nov; 98 (11):1653-1659
    View PubMed
  39. Kimball AB, Podda M, Alavi A, Miller M, Shen YK, Li S, Xu Y, Han C, Fakharzadeh S, Yang YW, DePrimo S, Munoz E, Chen Y, Passeron T, Papp K. Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study. J Eur Acad Dermatol Venereol. 2023 Oct; 37(10):2098-2108. Epub 2023 Jun 27.
    View PubMed
  40. Yamanaka-Takaichi M, Revankar R, Shih T, Gall M, Hsiao JL, Shi VY, Alavi A. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study. Arch Dermatol Res. 2023 Sep; 315 (7):2129-2136 Epub 2023 Mar 23
    View PubMed
  41. Isaq NA, Anand N, Camilleri MJ, Mohandesi NA, Alavi A. Neutrophilic eccrine hidradenitis: a retrospective study. Int J Dermatol. 2023 Sep; 62 (9):1142-1146 Epub 2023 June 23
    View PubMed
  42. Bellefeuille G, Paiewonsky B, Khalid B, Freese RL, Lowes MA, Kirby JS, Alavi A, Goldfarb N. Worst area local Hidradenitis suppurativa Activity and Severity Index-Revised (W-HASI-R): a study evaluating construct validity. Br J Dermatol. 2023 Aug 24; 189 (3):338-354
    View PubMed
  43. Hines AS, Mohandesi NA, Lehman JS, Koster MJ, Cantwell HM, Alavi A, Warrington KJ, Mangaonkar AA, Go RS, Patnaik MM, Sartori-Valinotti JC. Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings. Int J Dermatol. 2023 Jul; 62(7):938-945. Epub 2023 Mar 08.
    View PubMed
  44. Masson R, Shih T, Park S, De DR, Gierbolini A, Alavi A, Garg A, Micheletti R, Shi VY, Hsiao JL. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study Dermatology. 2023.
  45. Mistry J, Deo N, Vance P, Alavi A. Cutaneous Adverse Reactions Following Influenza Vaccination in Adults. Adv Skin Wound Care. 2023 Jun 01; 36(6):317-321.
    View PubMed
  46. Hines A, Butterfield R, Boudreaux B, Bhullar P, Severson KJ, McBane RD, Davis MDP, Pittelkow MR, Mangold AR, Alavi A. Characteristics of ulcerated and non-ulcerated necrobiosis lipoidica. Int J Dermatol. 2023 Jun; 62 (6):790-796 Epub 2022 Dec 07
    View PubMed
  47. Garg A, Rawal S, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen SR, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti RG, Miller AP, Moseng D, Naik HB, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis CC, Strunk A. Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol. 2023 May 24; 188(6):808-810.
    View PubMed
  48. Alavi A, Loftus EV Jr. Adalimumab Therapeutic Drug Monitoring Improves Treatment Outcome in Patients with Psoriasis. J Invest Dermatol. 2023 May 05. [Epub ahead of print]
    View PubMed
  49. Alavi A, Baradaran S, Mathias SD, Colwell HH, Song M, Hamzavi IH, Han C. Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom Diary. J Am Acad Dermatol. 2023 May; 88 (5):1123-1125 Epub 2021 Nov 19
    View PubMed
  50. Rick J, Gould LJ, Marzano AV, Garg A, Chen D, Oakes DL, Dissemond J, Herfarth H, Friedman MA, Alavi A, Yamamoto T, Gerbens LAA, Thomas KS, Ortega-Loayza AG. The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum. Arch Dermatol Res. 2023 May; 315 (4):983-988 Epub 2022 Oct 28
    View PubMed
  51. Pimentel MA, Li MM, Noe MH, Latour E, Seminario-Vidal L, Greiling T, Shinkai K, Hamilton A, Alavi A, Bolognia JL, Cowen EW, Dominguez A, Fernandez AP, Fivenson D, Huang WW, Madigan LM, Mauskar M, Means AD, Nelson CA, Patsatsi A, Pugliese D, Rojek NW, Rosenbach M, Smith GP, Swerlick RA, Heffernan MP, Mostaghimi A, Ortega-Loayza AG. Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. Br J Dermatol. 2023 Mar 30; 188 (4):566-568
    View PubMed
  52. Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Rueff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet. 2023 Mar 4; 401 (10378):747-761 Epub 2023 Feb 03
    View PubMed
  53. Alavi A, Anand N, Yamanaka-Takaichi M, Piguet V, Simmers J, Machado M, Todd A, Kirby J. Evaluating the hidradenitis odor and drainage scale (HODS): A new validated potential instrument to assess odor and drainage in hidradenitis suppurativa-A cross-sectional study. JAAD Int. 2023 Mar; 10:75-76. Epub 2022 Nov 15.
    View PubMed
  54. Bellefeuille G, Paiewonsky B, Khalid B, Freese RL, Lowes MA, Kirby JS, Alavi A, Goldfarb N. Inflammatory induration in hidradenitis suppurativa and application to severity assessment. Br J Dermatol. 2023 Feb 10; 188(2):309-310.
    View PubMed
  55. Garg A, Naik HB, Alavi A, Hazen P, Hsiao JL, Shi VY, Weisman J, Tran T, Rudnik J, Jedrzejczyk A, Pansar I, Kimball AB. Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data. Dermatol Ther (Heidelb). 2023 Feb; 13 (2):581-594 Epub 2022 Dec 31
    View PubMed
  56. Tzellos T, van Straalen KR, Kyrgidis A, Alavi A, Goldfarb N, Gulliver W, Jemec GBE, Lowes MA, Marzano AV, Prens EP, Sayed CJ, van der Zee HH, Zouboulis CC. Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2023 Feb; 37(2):395-401. Epub 2022 Oct 19.
    View PubMed
  57. Masson R, Shih T, Park S, De DR, Gierbolini A, Alavi A, Garg A, Micheletti RG, Shi VY, Hsiao JL. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study. Dermatology. 2023; 239 (5):732-737 Epub 2023 June 29
    View PubMed
  58. Yamanaka-Takaichi M, Raffals LE, Ehman EC, Loftus EV Jr, Alavi A. Anemia and Systemic Inflammatory Markers in Patients with Perianal Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease. Dermatology 2023; 239 (5):843-848 Epub 2023 June 23
    View PubMed
  59. van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romani J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort. Dermatology. 2023; 239 (3):362-367 Epub 2023 Jan 30
    View PubMed
  60. Midgette B, Strunk A, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen S, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad O, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti R, Miller AP, Moseng D, Naik H, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis C, Garg A. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol. 2022 Dec; 187 (6):927-935 Epub 2022 Sept 03
    View PubMed
  61. van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Dexhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romani J, Saunte DML, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. External Validation of the IHS4-55 in a European Antibiotic-Treated HS Cohort Dermatology. 11/30/2022.
  62. Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A. Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol. 2022 Nov; 61 (11):1372-1379 Epub 2022 Apr 29
    View PubMed
  63. Hanna N, Silverberg OM, Reaume M, Gladman D, Davis MDP, Piguet V, Alavi A. Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis. Int J Dermatol. 2022 Sep; 61 (9):1069-1079 Epub 2021 Aug 25
    View PubMed
  64. Rypka KJ, Fulk TS, Afsaneh A, Miller DD, Goldfarb NI. Improvement of Facial Discoid Dermatosis With Ustekinumab Treatment. JAMA Dermatol. 2022 Sep 1; 158 (9):1079-1080
    View PubMed
  65. Anand NC, Takaichi M, Johnson EF, Wetter DA, Davis MDP, Alavi A. Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases. Am J Clin Dermatol. 2022 Sep; 23(5):739-746. Epub 2022 Jul 18.
    View PubMed
  66. Croitoru D, Nathanielsz N, Seigel K, Elsawi R, Sibbald C, Alavi A, Zipursky J, Piguet V. Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review. J Am Acad Dermatol. 2022 Sep; 87 (3):655-656 Epub 2021 Dec 20
    View PubMed
  67. Mehta MM, Hanna N, Lowes MA, Alavi A. The incidence and risk of respiratory tract infections in patients using biologics for hidradenitis suppurativa: a systematic review and meta-analysis. Journal of Drugs in Dermatology. 2022 Aug; 21 (8):819-24
  68. Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Shayesteh Alam M, Papp KA, Desjardins O, Jean C. Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab. J Cutan Med Surg. 2022 Jul-Aug; 26 (4):361-370 Epub 2022 Mar 24
    View PubMed
  69. Deo N, Mastin M, Peters M, Wieland C, Alavi A. Multiple Nodules on the Bilateral Lower Extremities: Answer. Am J Dermatopathol. 2022 Jul 1; 44 (7):534
    View PubMed
  70. Anand N, Niezgoda J, Alavi A. 35 Years of Advances in Skin & Wound Care: Celebrating the Evolution of the Wound Care Team. Adv Skin Wound Care. 2022 Jul 1; 35 (7):360-362
    View PubMed
  71. Deo NN, Mastin MR, Peters MS, Wieland CN, Alavi A. Multiple Nodules on the Bilateral Lower Extremities: Challenge. Am J Dermatopathol. 2022 Jul 1; 44 (7):e69-e70
    View PubMed
  72. Yamanaka-Takaichi M, Ghanian S, Katzka DA, Torgerson RR, Alavi A. Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature. Am J Clin Dermatol. 2022 Jul; 23 (4):469-480 Epub 2022 Apr 15
    View PubMed
  73. Rick JW, De DR, Shih T, Alavi A, Kirby JS, Naik HB, Frew JW, Sayed CJ, Hsiao JL, Shi VY. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts. Skin Appendage Disord. 2022 Jul; 8 (4):287-290 Epub 2022 Jan 10
    View PubMed
  74. Shavit E, Alavi A. Get it off your chest: a narrative review of breast ulcers. Advances in Skin & Wound Care. 2022 Jun; 35 (6):306-13
  75. Vance P, Wyles S, Alavi A. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia. Adv Skin Wound Care. 2022 Jun 1; 35 (6):1-4
    View PubMed
  76. Alavi A, Hamzavi I, Brown K, Santos LL, Zhu Z, Liu H, Howell MD, Kirby JS. Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies. Br J Dermatol. 2022 May; 186 (5):803-813 Epub 2022 Mar 06
    View PubMed
  77. Ghanian S, Yamanaka-Takaichi M, Naik HB, Alavi A. Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New? Am J Clin Dermatol. 2022 Mar; 23 (2):167-176 Epub 2022 Jan 06
    View PubMed
  78. Lowes MA, Goldberg SR, Alavi A, Naik HB. Combining Medical and Surgical Management Strategies for Hidradenitis Suppurativa: Need for a Treat-to-Target Approach Dermatological Reviews. 2022.
  79. Rick JW, Shih T, Alavi A, Hsiao J, Shi V, Deveade. Lifestyle Modifications and Complementary Treatments for Hidradenitis Suppurativa Dermatological Reviews. 2022.
  80. Sachdeva M, Kim P, Mufti A, Maliyar K, Sibbald C, Alavi A. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg. 2022 Mar-Apr; 26(2):176-180. Epub 2021 Sep 29.
    View PubMed
  81. Kohn AH, Alavi A, Armstrong AW, Babalola F, Garg A, Gottlieb AB, Grilli L, Jemec GBE, Latella J, Marcus K, Merola JF, Ortega-Loayza AG, Siegel DM, Strand V, Tan JKL, Perez-Chada LM. International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting. Dermatology. 2022; 238 (3):430-437 Epub 2021 Sept 17
    View PubMed
  82. Sachdeva M, Lu JD, Croitoru D, Alavi A. Pyoderma Gangrenosum and Metabolic Comorbidities: A Systemic Review JCMS. 2022.
  83. Croitoru D, Nathanielsz N, Seigel K, Elsawi R, Sibbald C, Alavi A, Zipursky J, Piguet V. Treatment Outcomes for Pyoderma Gangrenosum on Rituximab Therapy: A Systemic Review JAAD. 2022.
  84. Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Alam MS, Papp KA, Desjardins O, Jean C. Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study. J Eur Acad Dermatol Venereol. 2021 Dec; 35 (12):2431-2439 Epub 2021 Aug 25
    View PubMed
  85. Gotesman RD, Choi C, Alavi A. Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis. Int J Dermatol. 2021 Nov; 60 (11):e433-e439 Epub 2021 June 01
    View PubMed
  86. Bechara FG, Podda M, Prens EP, Horvath B, Giamarellos-Bourboulis EJ, Alavi A, Szepietowski JC, Kirby J, Geng Z, Jean C, Jemec GBE, Zouboulis CC. Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial. JAMA Surg. 2021 Nov 1; 156 (11):1001-1009
    View PubMed
  87. Frew JW, Alavi A, Kirby JS. An Abscess Is Not a Descriptive Term but an Entity With a Universally Accepted Definition-A Clarification on Semantics-Reply. JAMA Dermatol 2021 Oct 1; 157 (10):1245-1246
    View PubMed
  88. Machado MO, Kang NC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Measuring fatigue: a meta-review. Int J Dermatol. 2021 Sep; 60 (9):1053-1069 Epub 2020 Dec 10
    View PubMed
  89. McPhie ML, Fletcher J, Machado MO, Carvalho AF, Piguet V, Alavi A. A Systematic Review of Depression and Anxiety in Adults with Pyoderma Gangrenosum. Adv Skin Wound Care. 2021 Aug 1; 34 (8):432-436
    View PubMed
  90. Silverberg JI, Pinter A, Alavi A, Lynde C, Bouaziz JD, Wollenberg A, Murrell DF, Alpizar S, Laquer V, Chaouche K, Ahmad F, Armstrong JM, Piketty C. Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI >/= 16) analysis of randomized phase 2B study. J Eur Acad Dermatol Venereol. 2021 Jul; 35 (7):1562-1568 Epub 2021 Apr 01
    View PubMed
  91. Hines A, Alavi A, Davis MDP. Cutaneous Manifestations of Diabetes. Med Clin North Am. 2021 Jul; 105(4):681-697.
    View PubMed
  92. Narla S, Azzam M, Townsend S, Vellaichamy G, Marzano AV, Alavi A, Lowes MA, Hamzavi IH. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. Br J Dermatol. 2021 Jun; 184(6):1004-1013. Epub 2021 Feb 01.
    View PubMed
  93. Goldfarb N, Lowes MA, Butt M, King T, Alavi A, Kirby JS. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment. Br J Dermatol. 2021 May; 184(5):905-912. Epub 2020 Dec 30.
    View PubMed
  94. Abdalla T, Lytvyn Y, McDonald KA, Mufti A, Alavi A. Cannabinoids in Dermatologic Surgery Journal of the American Academy of Dermatology. 2021. Epub 2021 May 17.
  95. Sibbald RG, Elliott JA, Persaud-Jaimangal R, Goodman L, Armstrong DG, Harley C, Coelho S, Xi N, Evans R, Mayer DO, Zhao X, Heil J, Kotru B, Delmore B, LeBlanc K, Ayello EA, Smart H, Tariq G, Alavi A, Somayaji R. Wound Bed Preparation 2021. Adv Skin Wound Care. 2021 Apr 1; 34 (4):183-195
    View PubMed
  96. Frew JW, Lowes MA, Goldfarb N, Butt M, Piguet V, O'Brien E, Ingram J, Jemec GBE, Tan J, Zouboulis C, Alavi A, Kirby JS. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary. JAMA Dermatol. 2021 Apr 1; 157 (4):449-455
    View PubMed
  97. Price KN, Collier EK, Grogan T, Fernandez JM, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Hsiao JL, Shi VY. Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatol Ther. 2021 Mar; 34 (2):e14851 Epub 2021 Feb 20
    View PubMed
  98. Abdalla T, Lowes MA, Kaur N, Micheletti RG, Steinhart AH, Alavi A. Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-alpha Inhibitors? Am J Clin Dermatol. 2021 Mar; 22 (2):139-147
    View PubMed
  99. Lu JD, Milakovic M, Piguet V, Alavi A. Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review. Br J Dermatol 2021 Mar; 184 (3):555-557 Epub 2021 Feb 08
    View PubMed
  100. Abdalla T, Mansour M, Bouazzi D, Lowes MA, Jemec GBE, Alavi A. Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series. Am J Clin Dermatol. 2021 Mar; 22(2):275-283. Epub 2020 Nov 26.
    View PubMed
  101. Alavi A, Goldenberg A, Jacob S, Shelley A, Kirsner R. Contact Dermatitis: An Important Consideration in Leg Ulcers International Journal of Women's Dermatology. 2021.
  102. Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delome I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball A, Kirby J, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein L, Piguet V, Sayed C, Tan J, Naik HB. Comorbidity Screening in Hidradenitis Suppurativa: Evidence-Based Recommendations from the US and Canadian Hidradenitis Suppurativa Foundations J Am Acad Dermatol. 01/22/2021. Epub 2021 Jan 04.
  103. Tai F, Shah M, Pon K, Alavi A. Laser Resurfacing Monotherapy for the Treatment of Actinic Keratosis. J Cutan Med Surg. 2021 Nov-Dec; 25(6):634-642. Epub 2021 Jul 02.
    View PubMed
  104. Alavi A, Archer J, Coutts P. Use of an advanced collagen matrix dressing on patients with complex chronic lower extremity ulcers: A case series. SAGE Open Med Case Rep. 2021; 9:2050313X211013684. Epub 2021 May 13.
    View PubMed
  105. Fletcher J, Posso-De Los Rios C, Jambrosic J, Alavi A. Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa? J Cutan Med Surg. 2021 Nov-Dec; 25(6):586-590. Epub 2021 Apr 28.
    View PubMed
  106. Shavit E, Cecchini M, Limacher JJ, Walsh S, Wentworth A, Davis MDP, Alavi A. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text]. J Cutan Med Surg. 2021 Jul-Aug; 25(4):371-376. Epub 2021 Feb 05.
    View PubMed
  107. Alavi A, Karvar M, Panayi A, Orgill DP, Ross K. Trends in The Management of Hidradenitis Suppurativa in the Middle East Region: A Systemic Review International Journal of Dermatology. 2020.
  108. Alavi A, Shi V, Hsiao J, Collier E, Seivright JR, Price K, Grogan TR, Fernandez JA. Provider Perspectives on the Management of Hidradenitis Suppurativa in Pregnancy - a Survey Study International Journal of Women's Dermatology. 2020.
  109. Pikety A, Silverberg J, Pinter A, Alavi A, Bouaziz JD. Nemolizumab is Associated with a Rapid Improvement in Atopic Dermatitis Signs and Symptoms: Subpopulation (EASI =16) Analysis of Phase 2B Study Journal of the European Academy of Dermatology and Venereology. 2020.
  110. Croitoru D, Naderi-Azad S, Sachdeva M, Piguet V, Alavi A. A Wound Care Specialist's Approach to Pyoderma Gangrenosum. Adv Wound Care (New Rochelle). 2020 Dec; 9(12):686-694. Epub 2020 Jun 16.
    View PubMed
  111. Sachdeva M, Shah M, Alavi A. Race-Specific Prevalence of Hidradenitis Suppurativa. J Cutan Med Surg. 2020 Nov 11; 1203475420972348 [Epub ahead of print]
    View PubMed
  112. Lu JD, Milakovic M, Ortega-Loayza AG, Marzano AV, Alavi A. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert Opin Investig Drugs. 2020 Nov; 29 (11):1179-1185 Epub 2020 Sept 29
    View PubMed
  113. Lu JD, Hobbs MM, Huang WW, Ortega-Loayza AG, Alavi A. Identification and evaluation of outcome measurement instruments in pyoderma gangrenosum: a systematic review. Br J Dermatol. 2020 Nov; 183(5):821-828. Epub 2020 May 07.
    View PubMed
  114. Shavit E, Marzano AV, Alavi A. Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis? Int J Dermatol. 2020 Oct 11 [Epub ahead of print]
    View PubMed
  115. Frew JW, Marzano AV, Wolk K, Join-Lambert O, Alavi A, Lowes MA, Piguet V. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. J Invest Dermatol. 2020 Sep 9 Epub 2020 Sept 09
    View PubMed
  116. Shah M, Sachdeva M, Alavi A. Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action. Int J Womens Dermatol. 2020 Sep; 6 (4):327-328 Epub 2020 May 31
    View PubMed
  117. Shavit E, Alavi A, George R. Inframammary Hidradenitis Suppurativa: An optimal surgical approach to a challenging region. Breast J. 2020 Aug 05. [Epub ahead of print]
    View PubMed
  118. Alavi A, Shah M, Kang NC. Inflamed, Purulent Axillary Nodules. Am Fam Physician. 2020 Jul 15; 102(2):111-112.
    View PubMed
  119. Price KN, Alavi A, Hsiao JL, Shi VY. Gender Minority Patients in Dermatology Clinical Trials International Journal of Women's Dermatology. 06/04/2020; 438-439.
  120. Narla S, Price KN, Sachdeva M, Shah M, Shi V, Hamzavi I, Alavi A, Lowes MA. Proceeding report of the fourth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2019. J Am Acad Dermatol. 2020 Jun 01. [Epub ahead of print]
    View PubMed
  121. Bezerra AP, Machado MO, Maes M, Marazziti D, Nunes-Neto PR, Solmi M, Firth J, Husain MI, Brunoni AR, Kurdyak P, Smith L, Alavi A, Piguet V, Carvalho AF. Trichotillomania-psychopathological correlates and associations with health-related quality of life in a large sample. CNS Spectr. 2020 Apr 08; 1-8. [Epub ahead of print]
    View PubMed
  122. Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. J Invest Dermatol. 2020 Mar; 140(3):531-536.e1. Epub 2019 Dec 20.
    View PubMed
  123. Shavit E, Pawliwec A, Alavi A, George R. The surgeon’s perspective: a retrospective study of wide local excisions taken to healthy subcutaneous fat in the management of advanced hidradenitis suppurativa Can J Surg. 2020 Feb 28; 63(2):E94-E99.
    View PubMed
  124. Mufti A, Maliyar K, Syed M, Pagnoux C, Alavi A. Approaches to Microthrombotic Wounds: A Review of Pathogenesis and Clinical Features. Adv Skin Wound Care. 2020 Feb; 33(2):68-75.
    View PubMed
  125. Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, Esmann S, Thorlacius L, Villumsen B, Marmol VD, Nassif A, Delage M, Tzellos T, Moseng D, Grimstad Ø, Naik H, Micheletti R, Guilbault S, Miller AP, Hamzavi I, van der Zee H, Prens E, Kappe N, Ardon C, Kirby B, Hughes R, Zouboulis CC, Nikolakis G, Bechara FG, Matusiak L, Szepietowski J, Glowaczewska A, Smith SD, Goldfarb N, Daveluy S, Avgoustou C, Giamarellos-Bourboulis E, Cohen S, Soliman Y, Brant EG, Akilov O, Sayed C, Tan J, Alavi A, Lowes MA, Pascual JC, Riad H, Fisher S, Cohen A, Paek SY, Resnik B, Ju Q, Wang L, Strunk A. Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020 Feb; 82(2):366-376. Epub 2019 Jul 03.
    View PubMed
  126. Price KN, Thompson AM, Rizvi O, Hendricks AJ, Alavi A, Hsiao JL, Shi VY. Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2020 Jan 29 [Epub ahead of print]
    View PubMed
  127. Amir Ali A, Seng EK, Alavi A, Lowes MA. Exploring changes in placebo treatment arms in hidradenitis suppurativa randomized clinical trials: A systematic review. J Am Acad Dermatol. 2020 Jan; 82(1):45-53. Epub 2019 May 29.
    View PubMed
  128. Tai F, Jakubovic H, Alabdulrazzaq S, Alavi A. A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report. SAGE Open Med Case Rep. 2020; 8:2050313X20919600. Epub 2020 May 18.
    View PubMed
  129. Alavi A. Use of an Advanced Collagen Matrix Dressing on Patients with Complex Chronic Lower Extremity Ulcers: A Case Series SAGE Open Medical Case Reports. 2020.
  130. Benhadou F, Van der Zee HH, Pascual JC, Rigopoulos D, Katoulis A, Liakou AI, Daxhelet M, Romanelli M, Iannone M, Kinyo A, Nikolakis G, Zouboulis CC, Dessinioti C, Zisimou C, Antoniou C, Alavi A, Mintoff D, Aquilina S, Matusiak L, Szepietowski JC, Sinclair R, Husein-ElAhmed H, von Laffert M, Revuz J, Danby B, Puig L, Theut Riis P, Jemec GBE, van Straalen K, Wigny KMGJ, Del Marmol V, Guillem P. Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients. Br J Dermatol. 2019 Dec; 181 (6):1198-1206 Epub 2019 May 06
    View PubMed
  131. Shavit E, Alkallabi M, Alavi A. Scalp ulcers - differential diagnoses that should be sought! Int J Dermatol. 2019 Nov; 58(11):1283-1292. Epub 2019 Jul 02.
    View PubMed
  132. Maliyar K, Mufti A, Syed M, Selk A, Dutil M, Bunce PE, Alavi A. Genital Ulcer Disease: A Review of Pathogenesis and Clinical Features. J Cutan Med Surg. 2019 Nov/Dec; 23(6):624-634. Epub 2019 Jun 28.
    View PubMed
  133. Rajabi-Estarabadi A, Kayssi A, Alavi A, Kirsner RS. Vascular Tests for Dermatologists. Am J Clin Dermatol. 2019 Oct; 20(5):657-667.
    View PubMed
  134. Alavi A, Piguet V. Genotype-phenotype correlation in inherited hidradenitis suppurativa: one step forward, one step back Br J Dermatol. 2019 Sep; 181(3):443-444.
  135. Huang CM, Lowes MA, Cserti C, Alavi A. Hemoglobin Levels and Serum C-Reactive Protein in Patients With Moderate to Severe Hidradenitis Suppurativa. J Cutan Med Surg. 2019 Sep/Oct; 23(5):501-506. Epub 2019 Jun 28.
    View PubMed
  136. Jfri AH, O'Brien EA, Litvinov IV, Alavi A, Netchiporouk E. Hidradenitis Suppurativa: Comprehensive Review of Predisposing Genetic Mutations and Changes. J Cutan Med Surg. 2019 Sep/Oct; 23(5):519-527. Epub 2019 Jun 06.
    View PubMed
  137. Byrd AS, Dina Y, Okoh UJ, Quartey QQ, Carmona-Rivera C, Williams DW, Kerns ML, Miller RJ, Petukhova L, Naik HB, Barnes LA, Shipman WD, Caffrey JA, Sacks JM, Milner SM, Aliu O, Broderick KP, Kim D, Liu H, Dillen CA, Ahn R, Frew JW, Kaplan MJ, Kang S, Garza LA, Miller LS, Alavi A, Lowes MA, Okoye GA. Specimen Collection for Translational Studies in Hidradenitis Suppurativa. Sci Rep. 2019 Aug 21; 9 (1):12207
    View PubMed
  138. Jfri A, O'Brien E, Alavi A, Goldberg SR. Association of hidradenitis suppurativa and keloid formation: A therapeutic challenge. JAAD Case Rep. 2019 Aug; 5 (8):675-678 Epub 2019 Aug 02
    View PubMed
  139. Posso-De Los Rios CJ, Sarfo A, Ghias M, Alhusayen R, Hamzavi I, Lowes MA, Alavi A. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Exp Dermatol. 2019 Jul; 28(7):769-775. Epub 2019 Apr 29.
    View PubMed
  140. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019 Jul; 81(1):76-90. Epub 2019 Mar 11.
    View PubMed
  141. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019 Jul; 81(1):91-101. Epub 2019 Mar 11.
    View PubMed
  142. Naik HB, Paul M, Cohen SR, Alavi A, Suàrez-Fariñas M, Lowes MA. Distribution of Self-reported Hidradenitis Suppurativa Age at Onset. JAMA Dermatol. 2019 Jun 05. [Epub ahead of print]
    View PubMed
  143. Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ, Shyu YC, Firth J, Koyanagi A, Solmi M, Alavi A, Piguet V, Carvalho AF. Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Jun 5 Epub 2019 June 05
    View PubMed
  144. Percival SL, Mayer D, Kirsner RS, Schultz G, Weir D, Roy S, Alavi A, Romanelli M. Surfactants: Role in biofilm management and cellular behaviour. Int Wound J. 2019 Jun; 16(3):753-760. Epub 2019 Mar 18.
    View PubMed
  145. McDonald KA, Shelley AJ, Pierscianowski T, Alavi A. A 2017 update: Challenging the cosmetic procedural delay following oral isotretinoin therapy. J Cosmet Laser Ther. 2019; 21(1):58-60. Epub 2018 Feb 28.
    View PubMed
  146. Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol. 2019 Jan; 28(1):94-103.
    View PubMed
  147. Naik HB, Nassif A, Ramesh MS, Schultz G, Piguet V, Alavi A, Lowes MA. Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017. J Invest Dermatol. 2019 Jan; 139(1):13-16. Epub 2018 Nov 08.
    View PubMed
  148. Fletcher J, Alhusayen R, Alavi A. Recent advances in managing and understanding pyoderma gangrenosum. F1000Res. 2019; 8. Epub 2019 Dec 12.
    View PubMed
  149. Alavi A, Shavit E, Archer J, Pagnoux C. Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association. SAGE Open Med Case Rep. 2019; 7:2050313X19882852. Epub 2019 Oct 21.
    View PubMed
  150. Sandhu VK, Alavi A. The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature. SAGE Open Med Case Rep. 2019; 7:2050313X19881594. Epub 2019 Oct 18.
    View PubMed
  151. Shavit E, Wollina U, Alavi A. Lipoedema is not lymphoedema: A review of current literature. Int Wound J. 2018 Dec; 15(6):921-928. Epub 2018 Jun 29.
    View PubMed
  152. Shavit E, Alavi A, Sibbald RG. Vasculitis-What Do We Have to Know? A Review of Literature. Int J Low Extrem Wounds. 2018 Dec; 17(4):218-226. Epub 2018 Dec 03.
    View PubMed
  153. Micieli R, Alavi A. Lymphedema in patients with hidradenitis suppurativa: a systematic review of published literature. Int J Dermatol. 2018 Dec; 57(12):1471-1480. Epub 2018 Aug 13.
    View PubMed
  154. Micieli R, Alavi A. Eruptive lentiginosis in resolving psoriatic plaques. JAAD Case Rep. 2018 Oct; 4(9):924-929. Epub 2018 Oct 10.
    View PubMed
  155. Mak J, Al Habeeb A, Al Kalabi M, Alavi A. Pyoderma Gangranosum-Like Blastomycosis. J Cutan Med Surg. 2018 Sep/Oct; 22(5):519-521. Epub 2018 Feb 28.
    View PubMed
  156. Almutairi D, Sheasgreen C, Weizman A, Alavi A. Generalized Pustular Psoriasis Induced by Infliximab in a Patient With Inflammatory Bowel Disease. J Cutan Med Surg. 2018 Sep/Oct; 22(5):507-510. Epub 2018 Feb 27.
    View PubMed
  157. Wang JY, Ighani A, Ayala AP, Akita S, Lara-Corrales I, Alavi A. Medical, Surgical, and Wound Care Management of Ulcerated Infantile Hemangiomas: A Systematic Review [Formula: see text]. J Cutan Med Surg. 2018 Sep/Oct; 22(5):495-504. Epub 2018 Apr 19.
    View PubMed
  158. Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatolog Treat. 2018 Jun; 29(4):383-384. Epub 2017 Oct 16.
    View PubMed
  159. Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018 Jun; 4(2):74-79. Epub 2018 Feb 01.
    View PubMed
  160. Mehdizadeh A, Rosella L, Alavi A, Sibbald G, Farzanfar D, Hazrati A, Vernich L, Laporte A, Hu H, Bashash M. A Canadian Population-Based Cohort to the Study Cost and Burden of Surgically Resected Hidradenitis Suppurativa. J Cutan Med Surg. 2018 May/Jun; 22 (3):312-317 Epub 2018 Mar 11
    View PubMed
  161. Almutairi D, LeBlanc K, Alavi A. Peristomal skin complications: what dermatologists need to know. Int J Dermatol. 2018 Mar; 57(3):257-264. Epub 2017 Aug 22.
    View PubMed
  162. Alavi A, Farzanfar D, Lee RK, Almutairi D. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa. J Cutan Med Surg. 2018 Mar/Apr; 22(2):166-174. Epub 2017 Dec 12.
    View PubMed
  163. Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-Induced Pyoderma Gangrenosum: A Review. Am J Clin Dermatol. 2018 Feb; 19(1):67-77.
    View PubMed
  164. Micieli R, Alavi A. Treatment for Livedoid Vasculopathy: A Systematic Review. JAMA Dermatol. 2018 Feb 01; 154(2):193-202.
    View PubMed
  165. Shavit E, Alavi A, Limacher JJ, Sibbald RG. Angiosarcoma complicating lower leg elephantiasis in a male patient: An unusual clinical complication, case report and literature review. SAGE Open Med Case Rep. 2018; 6:2050313X18796343. Epub 2018 Oct 30.
    View PubMed
  166. Hoffman LK, Tomalin LE, Schultz G, Howell MD, Anandasabapathy N, Alavi A, Suárez-Fariñas M, Lowes MA. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature. PLoS One. 2018; 13(9):e0203672. Epub 2018 Sep 28.
    View PubMed
  167. Farzanfar D, Dowlati Y, French LE, Lowes MA, Alavi A. Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease. Skin Pharmacol Physiol. 2018; 31(5):246-251. Epub 2018 Jun 28.
    View PubMed
  168. Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD. Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA). Exp Dermatol. 2018 Jan; 27(1):104-112. Epub 2017 Nov 15.
    View PubMed
  169. Shavit E, Alavi A, Sibbald RG. Pyoderma Gangrenosum: A Critical Appraisal. Adv Skin Wound Care. 2017 Dec; 30(12):534-542.
    View PubMed
  170. Mistry BD, Alavi A, Ali S, Mistry N. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus. Int J Dermatol. 2017 Dec; 56(12):1319-1327. Epub 2017 Jun 26.
    View PubMed
  171. Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document. J Cutan Med Surg. 2017 Nov/Dec; 21(6):513-524. Epub 2017 Jun 22.
    View PubMed
  172. McDonald KA, Shelley AJ, Alavi A. A Systematic Review on Oral Isotretinoin Therapy and Clinically Observable Wound Healing in Acne Patients. J Cutan Med Surg. 2017 Jul/Aug; 21 (4):325-333 Epub 2017 Mar 31
    View PubMed
  173. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017 Jun; 18(3):355-372.
    View PubMed
  174. Antia C, Alavi A, Alikhan A. Topical management and wound care approaches for hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):58-61.
    View PubMed
  175. Hoffman LK, Ghias MH, Garg A, Hamzavi IH, Alavi A, Lowes MA. Major gaps in understanding and treatment of hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):86-92.
    View PubMed
  176. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M, SOLO 1 and SOLO 2 Investigators. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016 Dec 15; 375 (24):2335-2348 Epub 2016 Sept 30
    View PubMed
  177. Yang GK, Cao S, Kayssi A, Dueck AD, Alavi A. Critical Evaluation of Delayed Healing of Venous Leg Ulcers: A Retrospective Analysis in Canadian Patients. Am J Clin Dermatol. 2016 Oct; 17(5):539-544.
    View PubMed
  178. Alavi A. Discussion: What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plast Reconstr Surg 2016 Sep; 138 (3 Suppl):230S-231S
    View PubMed
  179. Alavi A, Sibbald RG, Ladizinski B, Saraiya A, Lee KC, Skotnicki-Grant S, Maibach H. Wound-Related Allergic/Irritant Contact Dermatitis. Adv Skin Wound Care. 2016 Jun; 29(6):278-86.
    View PubMed
  180. Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A Review of Our Current Understanding. Am J Clin Dermatol. 2016 Jun; 17(3):277-92.
    View PubMed
  181. Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS. What's new: Management of venous leg ulcers: Treating venous leg ulcers. J Am Acad Dermatol. 2016 Apr; 74(4):643-64; quiz 665-6.
    View PubMed
  182. Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS. What's new: Management of venous leg ulcers: Approach to venous leg ulcers. J Am Acad Dermatol. 2016 Apr; 74(4):627-40; quiz 641-2.
    View PubMed
  183. Ghasemi F, Anooshirvani N, Sibbald RG, Alavi A. The Point Prevalence of Malignancy in a Wound Clinic. Int J Low Extrem Wounds. 2016 Mar; 15(1):58-62.
    View PubMed
  184. Criado PR, Alavi A, Valente NY, Sotto MN. Amantadine-Induced Livedo Racemosa. Int J Low Extrem Wounds. 2016 Mar; 15(1):78-81. Epub 2015 Sep 03.
    View PubMed
  185. Alavi A, Cohen AD, Gulliver W, Brassard A, Danby WB, Zouboulis CC. CHSF / HSF / EHSF joint pre-WCD Hidradenitis Suppurativa Symposium, Vancouver, Canada, June 6, 2015. Exp Dermatol. 2016 Feb; 25 Suppl 1:1-9.
    View PubMed
  186. Mufti A, Al-Mohammedi F, Alavi A. An unusual presentation of Vilanova disease (erythema nodosum migrans) with superficial histologic changes. JAAD Case Rep. 2016 Jan; 2(1):41-3. Epub 2016 Jan 29.
    View PubMed
  187. Kim WB, Sibbald RG, Hu H, Bashash M, Anooshirvani N, Coutts P, Alavi A. Clinical Features and Patient Outcomes of Hidradenitis Suppurativa: A Cross-Sectional Retrospective Study. J Cutan Med Surg. 2016 Jan; 20(1):52-7. Epub 2015 Aug 28.
    View PubMed
  188. Alavi A, Sibbald RG, Nabavizadeh R, Valaei F, Coutts P, Mayer D. Audible handheld Doppler ultrasound determines reliable and inexpensive exclusion of significant peripheral arterial disease. Vascular. 2015 Dec; 23(6):622-9. Epub 2015 Jan 27.
    View PubMed
  189. Alavi A, Kirsner RS. Local wound care and topical management of hidradenitis suppurativa. J Am Acad Dermatol. 2015 Nov; 73(5 Suppl 1):S55-61.
    View PubMed
  190. Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, Sibbald RG, Alavi A. Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. J Am Acad Dermatol. 2015 Nov; 73(5 Suppl 1):S70-7.
    View PubMed
  191. Okhovat JP, Alavi A. Lipedema: A Review of the Literature. Int J Low Extrem Wounds. 2015 Sep; 14(3):262-7. Epub 2014 Oct 17.
    View PubMed
  192. Wang SC, Wang SC, Alavi A, Alhusayen R, Bashash M, Sibbald RG. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options. Adv Skin Wound Care. 2015 Aug; 28 (8):372-80; quiz 381-2
    View PubMed
  193. Wang SC, Wang SC, Sibbald RG, Alhusayen R, Bashash M, Alavi A. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features. Adv Skin Wound Care. 2015 Jul; 28(7):325-32; quiz 333-4.
    View PubMed
  194. Criado PR, de Souza EspinelI DP, Valentef NS, Alavi A, Kirsner RS. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol. Dermatol Ther. 2015 Jul-Aug; 28(4):248-53. Epub 2015 Mar 30.
    View PubMed
  195. Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015 Jul; 33(3):343-60.
    View PubMed
  196. Criado PR, Grizzo Peres Martins AC, Gaviolli CF, Alavi A. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody. Int J Low Extrem Wounds. 2015 Jun; 14(2):187-91. Epub 2014 Sep 25.
    View PubMed
  197. Kim WB, Alavi A, Pope E, Walsh S. Epidermolysis Bullosa Pruriginosa: Case Series and Review of the Literature. Int J Low Extrem Wounds. 2015 Jun; 14(2):196-9. Epub 2015 Feb 17.
    View PubMed
  198. Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015 May; 28(5):228-36; quiz 237-8.
    View PubMed
  199. Kim WB, Alavi A, Walsh S, Kim S, Pope E. Epidermolysis bullosa pruriginosa: a systematic review exploring genotype-phenotype correlation. Am J Clin Dermatol. 2015 Apr; 16(2):81-7.
    View PubMed
  200. Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2015 Feb; 16(1):61-5.
    View PubMed
  201. Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care. 2014 Nov; 27(11):518-24; quiz 525-6.
    View PubMed
  202. Bader MS, Alavi A. Management of hospitalized patients with diabetic foot infections. Hosp Pract (1995). 2014 Oct; 42(4):111-25.
    View PubMed
  203. Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update. Am J Clin Dermatol. 2014 Oct; 15(5):413-23.
    View PubMed
  204. Ladizinski B, Alavi A, Jambrosic J, Mistry N, Sibbald RG. Cancers mimicking fungal infections. Adv Skin Wound Care. 2014 Jul; 27(7):301-9.
    View PubMed
  205. Criado PR, Alavi A, Kirsner RS. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers. Int J Low Extrem Wounds. 2014 Jun; 13(2):130-134. Epub 2014 May 25.
    View PubMed
  206. Kim WB, Mistry N, Alavi A, Sibbald C, Sibbald RG. Pretibial Myxedema: Case Presentation and Review of Treatment Options. Int J Low Extrem Wounds. 2014 Jun; 13(2):152-154. Epub 2014 May 07.
    View PubMed
  207. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol. 2014 Jan; 70(1):21.e1-24; quiz 45-6.
    View PubMed
  208. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014 Jan; 70(1):1.e1-18; quiz 19-20.
    View PubMed
  209. Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol. 2013 Dec; 69(6):1033-1042.e1. Epub 2013 Sep 09.
    View PubMed
  210. Criado PR, Alavi A, Halpern I, Sotto MN, Kirsner RS. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders. Int J Low Extrem Wounds. 2013 Dec; 12(4):306-9. Epub 2013 Sep 16.
    View PubMed
  211. Woo KY, Botros M, Kuhnke J, Evans R, Alavi A. Best practices for the management of foot ulcers in people with diabetes. Adv Skin Wound Care. 2013 Nov; 26(11):512-24; quiz 225-6.
    View PubMed
  212. Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013 Nov; 69(5):783-791. Epub 2013 Aug 19.
    View PubMed
  213. Woo KY, Alavi A, Evans R, Despatis M, Allen J. New advances in compression therapy for venous leg ulcers. Surg Technol Int. 2013 Sep; 23:61-8.
    View PubMed
  214. Ladizinski B, Lee KC, Wilmer E, Alavi A, Mistry N, Sibbald RG. A review of the clinical variants and the management of psoriasis. Adv Skin Wound Care. 2013 Jun; 26(6):271-84; quiz 285-6.
    View PubMed
  215. Ghiasi N, Alavi A, Coutts PM, Ghazarian D, Sibbald RG. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration. Int J Low Extrem Wounds. 2012 Dec; 11(4):293-5.
    View PubMed
  216. Alavi A, Mayer D, Hafner J, Sibbald RG. Martorell hypertensive ischemic leg ulcer: an underdiagnosed Entity©. Adv Skin Wound Care. 2012 Dec; 25(12):563-72; quiz 573-4.
    View PubMed
  217. Alavi A, Lowe J, Walsh S, Juurlink D, Mortaz-Hedjri S, Shear NH. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus. Int J Dermatol. 2012 Oct; 51(10):1248-52.
    View PubMed
  218. Sibbald RG, Ayello EA, Alavi A, Ostrow B, Lowe J, Botros M, Goodman L, Woo K, Smart H. Screening for the high-risk diabetic foot: a 60-second tool (2012). Adv Skin Wound Care. 2012 Oct; 25(10):465-76; quiz 477-8.
    View PubMed
  219. Ladizinski B, Bazakas A, Mistry N, Alavi A, Sibbald RG, Salcido R. Sickle cell disease and leg ulcers. Adv Skin Wound Care. 2012 Sep; 25(9):420-8.
    View PubMed
  220. Alavi A, Skotnicki S, Sussman G, Sibbald RG. Diagnosis and treatment of hand dermatitis. Adv Skin Wound Care. 2012 Aug; 25(8):371-80; quiz 381-2.
    View PubMed
  221. Sanjari M, Safari S, Shokoohi M, Safizade H, Rashidinezhad H, Mashrouteh M, Alavi A. A cross-sectional study in Kerman, Iran, on the effect of diabetic foot ulcer on health-related quality of life. Int J Low Extrem Wounds. 2011 Dec; 10(4):200-6.
    View PubMed
  222. Alavi A, Niakosari F, Sibbald RG. When and how to perform a biopsy on a chronic wound. Adv Skin Wound Care. 2010 Mar; 23(3):132-40; quiz 141-2.
    View PubMed
  223. Alavi A, Sanjari M, Haghdoost A, Sibbald RG. Common foot examination features of 247 Iranian patients with diabetes. Int Wound J. 2009 Apr; 6(2):117-22.
    View PubMed
  224. Smart V, Alavi A, Coutts P, Fierheller M, Coelho S, Linn Holness D, Sibbald RG. Contact allergens in persons with leg ulcers: a Canadian study in contact sensitization. Int J Low Extrem Wounds. 2008 Sep; 7(3):120-5.
    View PubMed
  225. Alavi A, Woo K, Sibbald RG. Common nail disorders and fungal infections. Adv Skin Wound Care. 2007 Jun; 20(6):346-57; quiz 357-9.
    View PubMed
  226. Alavi A. Wound care challenges faced in iran. Adv Skin Wound Care. 2007 Jan; 20(1):27-8.
    View PubMed
  227. Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2002 Aug; 41(8):521-4.
    View PubMed